Cargando…
Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer
BACKGROUND: Aberrant regulation of glycogen synthase kinase-3β (GSK-3β) has been implicated in several human cancers; however, it has not been reported in the gastric cancer tissues to date. The present study was performed to determine the expression status of active form of GSK-3β phosphorylated at...
Autores principales: | Cho, Yu Jin, Kim, Ji Hun, Yoon, Jiyeon, Cho, Sung Jin, Ko, Young San, Park, Jong-Wan, Lee, Hye Seung, Lee, Hee Eun, Kim, Woo Ho, Lee, Byung Lan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928182/ https://www.ncbi.nlm.nih.gov/pubmed/20704706 http://dx.doi.org/10.1186/1471-230X-10-91 |
Ejemplares similares
-
Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis
por: Park, Hyunsoo, et al.
Publicado: (2016) -
Glycogen synthase kinase 3β suppresses polyglutamine aggregation by inhibiting Vaccinia-related kinase 2 activity
por: Lee, Eunju, et al.
Publicado: (2016) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016) -
CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death through Cyclin D1 Depletion in Breast Cancer Cells
por: Kim, Hyun Mi, et al.
Publicado: (2013)